Investor Centre
Corporate Governance
Paragon Care Limited (ASX:PGC) and the Board are committed to achieving and demonstrating the highest standards of corporate governance. ParagonCare aims to meet the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations, which are reviewed annually and approved by the Board.
Home | Investor Hub | Corporate Governance
Board & Executive Team
Our board and executive team bring deep expertise across healthcare, distribution, finance and operations.
Carmen Riley
Chief Executive Officer & MD
Carmen Riley
Chief Executive Officer & MD
Carmen Riley became Managing Director on 1 March 2026 after being appointed CEO on 1 July 2025. Carmen was appointed to the CH2 Holdings board of directors in July 2019 and to ParagonCare Ltd in June 2024. Carmen was instrumental in bringing Oborne, ParagonCare, and CH2 together. She became Chief Operating Officer in 2017 after transitioning from General Manager of Sales.
Before joining CH2 Holdings Carmen was CEO of PQ Lifestyles (Intouch) from July 2008, which was successfully acquired by CH2 Holdings in 2010. Prior to joining the Healthcare industry Carmen had an extensive career within FMCG, across Supply Chain, Operations, Finance and Project Management. Carmen’s experience provides strong financial and operational management skills gained from both private and ASX listed companies.
Peter Lacaze
Chairman
Peter Lacaze
Chairman
Peter Lacaze is the Chairman and 28.5% owner of ParagonCare. Peter was a 50% shareholder of CH2 Holdings prior to the completion of the reverse acquisition.
Peter has been involved in CH2 Holdings since 2006 as a minority shareholder and was the Chief Executive Officer between 2006 to 2008. Peter became the Chairman of CH2 Holdings in December 2015 when David and Peter acquired 100% of CH2 Holdings Pty Ltd.
As an experienced Australian business leader, Peter has worked in a number of industries with particular emphasis on healthcare and travel. Peter brings a dynamic and practical approach with a long-term lens on driving business performance.
David Collins
Non Executive Director, M&A
David Collins
Non Executive Director, M&A
David Collins transitioned to the role of Executive Director and Mergers & Acquisitions on the 1 March 2026. He holds a 28.5% ownership stake in the Group.
David was appointed as CEO and Managing Director in December 2015 of CH2 Holdings when David and Peter Lacaze acquired 100% of CH2 Holdings Pty Ltd. David has been with CH2 Holdings since 2005 starting as Chief Financial Officer and then moving into the Managing Director role in 2008 until 2014. In 2006 David became a minority shareholder of CH2 Holdings. David spent 20 months as the Chief Financial Officer at Greencross Health Limited in Auckland. David brings unparalleled experience and extensive knowledge of the Australian and New Zealand healthcare wholesale and distribution sectors.
Prior to CH2 Holdings David held senior finance and management roles in both Australia and New Zealand, predominantly in the pharmaceutical wholesaling industries.
John Walstab
Non Executive Director
John Walstab
Non Executive Director
John was appointed as CEO and Managing Director on 1 October 2023 and resigned on 3 June 2024. He continued as Executive Director until 31 March 2025.
John has led a strong team to successfully build Quantum Health Group's medical equipment business across the Asia Pacific region, prior to ParagonCare acquiring Quantum in February 2022. Post-acquisition Quantum Health Group formed the core platform for ParagonCare's growth in Asia. John has over 40 years' experience in medical equipment distribution with a focus on leading-edge healthcare technologies in Asia and was the founder of Quantum Health Group in 1998 (formerly Insight Oceania).
John's prior roles include Managing Director of Advanced Technology Laboratories (Philips Medical Systems ANZ), and Business Manager for Medtel Australia. John is a member of the Australian Institute of Company Directors and sits on various Boards including Central Sydney Private Hospital, CBTR Healthcare Solutions, and SMS Healthcare.
Peter Egglestone
Non Executive Director
Peter Egglestone
Non Executive Director
Peter is a senior executive and has more than 25 years leadership, financial and commercial experience.
Peter is the Managing Director and CEO of Aero Travel Solutions Pty Limited - an air ticketing technology provider and wholesaler operating in Australia, United States and Southern Africa.
Prior to that Peter was CEO of one of Australia's leading payment facilitators. In addition, Peter has held a number of C-Suite positions including for private equity business Journey Beyond, where he successfully led all revenue functions, including sales, marketing, revenue management and customer relations.
Peter has a finance and economics background having spent many of his formative years in Corporate and Statutory Accounting.
Carmen Riley
Chief Executive Officer & MD
Carmen Riley became Managing Director on 1 March 2026 after being appointed CEO on 1 July 2025. Carmen was appointed to the CH2 Holdings board of directors in July 2019 and to ParagonCare Ltd in June 2024. Carmen was instrumental in bringing Oborne, ParagonCare, and CH2 together. She became Chief Operating Officer in 2017 after transitioning from General Manager of Sales.
Before joining CH2 Holdings Carmen was CEO of PQ Lifestyles (Intouch) from July 2008, which was successfully acquired by CH2 Holdings in 2010. Prior to joining the Healthcare industry Carmen had an extensive career within FMCG, across Supply Chain, Operations, Finance and Project Management. Carmen’s experience provides strong financial and operational management skills gained from both private and ASX listed companies.
David Collins
Non Executive Director, M&A
David Collins transitioned to the role of Executive Director and Mergers & Acquisitions on the 1 March 2026. He holds a 28.5% ownership stake in the Group.
David was appointed as CEO and Managing Director in December 2015 of CH2 Holdings when David and Peter Lacaze acquired 100% of CH2 Holdings Pty Ltd. David has been with CH2 Holdings since 2005 starting as Chief Financial Officer and then moving into the Managing Director role in 2008 until 2014. In 2006 David became a minority shareholder of CH2 Holdings. David spent 20 months as the Chief Financial Officer at Greencross Health Limited in Auckland. David brings unparalleled experience and extensive knowledge of the Australian and New Zealand healthcare wholesale and distribution sectors.
Prior to CH2 Holdings David held senior finance and management roles in both Australia and New Zealand, predominantly in the pharmaceutical wholesaling industries.
Peter Lacaze
Chairman
Peter Lacaze is the Chairman and 28.5% owner of ParagonCare. Peter was a 50% shareholder of CH2 Holdings prior to the completion of the reverse acquisition.
Peter has been involved in CH2 Holdings since 2006 as a minority shareholder and was the Chief Executive Officer between 2006 to 2008. Peter became the Chairman of CH2 Holdings in December 2015 when David and Peter acquired 100% of CH2 Holdings Pty Ltd.
As an experienced Australian business leader, Peter has worked in a number of industries with particular emphasis on healthcare and travel. Peter brings a dynamic and practical approach with a long-term lens on driving business performance.
John Walstab
Non Executive Director
John was appointed as CEO and Managing Director on 1 October 2023 and resigned on 3 June 2024. He continued as Executive Director until 31 March 2025.
John has led a strong team to successfully build Quantum Health Group's medical equipment business across the Asia Pacific region, prior to ParagonCare acquiring Quantum in February 2022. Post-acquisition Quantum Health Group formed the core platform for ParagonCare's growth in Asia. John has over 40 years' experience in medical equipment distribution with a focus on leading-edge healthcare technologies in Asia and was the founder of Quantum Health Group in 1998 (formerly Insight Oceania).
John's prior roles include Managing Director of Advanced Technology Laboratories (Philips Medical Systems ANZ), and Business Manager for Medtel Australia. John is a member of the Australian Institute of Company Directors and sits on various Boards including Central Sydney Private Hospital, CBTR Healthcare Solutions, and SMS Healthcare.
Peter Egglestone
Non Executive Director
Peter is a senior executive and has more than 25 years leadership, financial and commercial experience.
Peter is the Managing Director and CEO of Aero Travel Solutions Pty Limited - an air ticketing technology provider and wholesaler operating in Australia, United States and Southern Africa.
Prior to that Peter was CEO of one of Australia's leading payment facilitators. In addition, Peter has held a number of C-Suite positions including for private equity business Journey Beyond, where he successfully led all revenue functions, including sales, marketing, revenue management and customer relations.
Peter has a finance and economics background having spent many of his formative years in Corporate and Statutory Accounting.
Corporate Governance Documents
Corporate Directory
Registered Office
ParagonCare Limited
PGC.ASX
ABN: 76 064 551 426
Site Address
77-97 Ricketts Road
Mt Waverley VIC 3149 Australia
Mailing Address
Paragon Care Limited PO Box 229 Mt Waverley VIC 3149 Australia
Phone
Toll-free (Aus only) 1300 369 559 T: +61 3 8833 7800 F: +61 3 8833 7890
Company Secretary
Mr Michael Sapountzis
Organisation
Vistra Australia
Address
Level 11, 385 Bourke Street,
Melbourne VIC 3000
Phone
+613 9692 7222
Tax
+613 9077 9233
Email
[email protected]
Legal
Baker McKenzie
181 William Street, Melbourne VIC 3000
Bankers
National Australia Bank
HSBC Bank Australia
Scottish Pacific Business Finance Pty Ltd
Auditors
Ernst & Young
8 Exhibition Street, Melbourne VIC 3000
Share Registry
MUFG Corporate
Markets (AU) Limited
Tower 4, 727 Collins Street, Docklands VIC 3008
Registered Office
Paragon Care Limited
PGC.ASX ABN:
76 064 551 426
Site Address
77-97 Ricketts Road Mt Waverley VIC 3149 Australia
Mailing Address
Paragon Care Limited PO Box 229 Mt Waverley VIC 3149 Australia
Phone
Toll-free (Aus only) 1300 369 559 T: +61 3 8833 7800 F: +61 3 8833 7890
Company Secretary
Mr Michael Sapountzis
Organisation
Vistra Australia
Address
Level 11, 385 Bourke Street, Melbourne VIC 3000
Phone
+613 9692 7222
Tax
+613 9077 9233
Email
[email protected]
Legal
Baker McKenzie
181 William Street, Melbourne VIC 3000
Bankers
National Australia Bank
HSBC Bank Australia
Scottish Pacific Business Finance Pty Ltd
Auditors
Ernst & Young
8 Exhibition Street, Melbourne VIC 3000
Share Registry
MUFG Corporate Markets (AU) Limited
Tower 4, 727 Collins Street, Docklands VIC 3008